Literature DB >> 34350506

Next-Generation Sequencing Reveals Novel Genetic Variants for Dilated Cardiomyopathy in Pediatric Chinese Patients.

Yan Wang1,2, Bo Han3,4, Youfei Fan2, Yingchun Yi2, Jianli Lv2, Jing Wang2, Xiaofei Yang2, Diandong Jiang2, Lijian Zhao2, Jianjun Zhang2, Hui Yuan2.   

Abstract

Dilated cardiomyopathy (DCM) is a myocardial disease characterized by bilateral or left ventricular cardiac dilation and systolic dysfunction that can lead to heart failure and sudden cardiac death in children. Many studies have focused on genetic variation in DCM-related genes in adult populations; however, the mutational landscape in pediatric DCM patients remains undetermined, especially in the Chinese population. We applied next-generation sequencing (NGS) technology to genetically analyze 46 pediatric DCM patients to reveal genotype-phenotype correlations. Our results indicated DCM-associated pathogenic mutations in 10 genes related to the structure or function of the sarcomere, desmosome, and cytoskeleton. We also identified 6 pathogenic mutations (5 novel) in the Titin (TTN) gene that resulted in truncated TTN variants in 6 (13%) out of 46 patients. Correlations between TTN mutations and clinical outcomes were assessed. Our data indicate that one-third of pediatric DCM cases are caused by genetic mutations. The role of TTN variants should not be underestimated in pediatric DCM and age-dependent pathogenic penetrance of these mutations should be considered for familial DCM cases. We argue that genetic testing of DCM cases is valuable for predicting disease severity, prognosis, and recurrence risk, and for screening first-degree relatives.
© 2021. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Dilated cardiomyopathy; Genetic testing; Mutation; Pediatric patient; Titin

Mesh:

Year:  2021        PMID: 34350506     DOI: 10.1007/s00246-021-02698-8

Source DB:  PubMed          Journal:  Pediatr Cardiol        ISSN: 0172-0643            Impact factor:   1.655


  38 in total

Review 1.  Genetic basis of dilated cardiomyopathy.

Authors:  Alexandra Pérez-Serra; Rocio Toro; Georgia Sarquella-Brugada; David de Gonzalo-Calvo; Sergi Cesar; Esther Carro; Vicenta Llorente-Cortes; Anna Iglesias; Josep Brugada; Ramon Brugada; Oscar Campuzano
Journal:  Int J Cardiol       Date:  2016-09-21       Impact factor: 4.164

2.  Long-term prognostic impact of therapeutic strategies in patients with idiopathic dilated cardiomyopathy: changing mortality over the last 30 years.

Authors:  Marco Merlo; Alberto Pivetta; Bruno Pinamonti; Davide Stolfo; Massimo Zecchin; Giulia Barbati; Andrea Di Lenarda; Gianfranco Sinagra
Journal:  Eur J Heart Fail       Date:  2013-12-14       Impact factor: 15.534

3.  De novo RRAGC mutation activates mTORC1 signaling in syndromic fetal dilated cardiomyopathy.

Authors:  Michael T Zimmermann; Maengjo Kim; Pamela A Long; Jared M Evans; Xiaolei Xu; Timothy M Olson
Journal:  Hum Genet       Date:  2016-05-27       Impact factor: 4.132

Review 4.  The genetics of dilated cardiomyopathy.

Authors:  Lisa Dellefave; Elizabeth M McNally
Journal:  Curr Opin Cardiol       Date:  2010-05       Impact factor: 2.161

5.  The epidemiology of childhood cardiomyopathy in Australia.

Authors:  Alan W Nugent; Piers E F Daubeney; Patty Chondros; John B Carlin; Michael Cheung; Lynette C Wilkinson; Andrew M Davis; Stephen G Kahler; C W Chow; James L Wilkinson; Robert G Weintraub
Journal:  N Engl J Med       Date:  2003-04-24       Impact factor: 91.245

Review 6.  Inherited cardiomyopathies.

Authors:  Hugh Watkins; Houman Ashrafian; Charles Redwood
Journal:  N Engl J Med       Date:  2011-04-28       Impact factor: 91.245

7.  The Pediatric Cardiomyopathy Registry: 1995-2007.

Authors:  James D Wilkinson; Lynn A Sleeper; Jorge A Alvarez; Natalya Bublik; Steven E Lipshultz
Journal:  Prog Pediatr Cardiol       Date:  2008-04

Review 8.  Cardiomyopathy, familial dilated.

Authors:  Matthew R G Taylor; Elisa Carniel; Luisa Mestroni
Journal:  Orphanet J Rare Dis       Date:  2006-07-13       Impact factor: 4.123

9.  Genetics and genotype-phenotype correlations in Finnish patients with dilated cardiomyopathy.

Authors:  Oyediran Akinrinade; Laura Ollila; Sanna Vattulainen; Jonna Tallila; Massimiliano Gentile; Pertteli Salmenperä; Hannele Koillinen; Maija Kaartinen; Markku S Nieminen; Samuel Myllykangas; Tero-Pekka Alastalo; Juha W Koskenvuo; Tiina Heliö
Journal:  Eur Heart J       Date:  2015-06-17       Impact factor: 29.983

Review 10.  Genetics of Human and Canine Dilated Cardiomyopathy.

Authors:  Siobhan Simpson; Jennifer Edwards; Thomas F N Ferguson-Mignan; Malcolm Cobb; Nigel P Mongan; Catrin S Rutland
Journal:  Int J Genomics       Date:  2015-07-22       Impact factor: 2.326

View more
  3 in total

1.  The genetic architecture of pediatric cardiomyopathy.

Authors:  Stephanie M Ware; Surbhi Bhatnagar; Phillip J Dexheimer; James D Wilkinson; Arthi Sridhar; Xiao Fan; Yufeng Shen; Muhammad Tariq; Jeffrey A Schubert; Steven D Colan; Ling Shi; Charles E Canter; Daphne T Hsu; Neha Bansal; Steven A Webber; Melanie D Everitt; Paul F Kantor; Joseph W Rossano; Elfriede Pahl; Paolo Rusconi; Teresa M Lee; Jeffrey A Towbin; Ashwin K Lal; Wendy K Chung; Erin M Miller; Bruce Aronow; Lisa J Martin; Steven E Lipshultz
Journal:  Am J Hum Genet       Date:  2022-01-12       Impact factor: 11.043

2.  Clinical Profile and Risk Factors for Cardiac Death in Pediatric Patients With Primary Dilated Cardiomyopathy at a Tertiary Medical Center in China.

Authors:  Yan Wang; Bo Han; Youfei Fan; Yingchun Yi; Jianli Lv; Jing Wang; Xiaofei Yang; Diandong Jiang; Lijian Zhao; Jianjun Zhang; Hui Yuan
Journal:  Front Pediatr       Date:  2022-04-28       Impact factor: 3.418

3.  Transcriptome analysis uncovers the autophagy-mediated regulatory patterns of the immune microenvironment in dilated cardiomyopathy.

Authors:  Shuo Sun; Jiangting Lu; Chaojie Lai; Zhaojin Feng; Xia Sheng; Xianglan Liu; Yao Wang; Chengchen Huang; Zhida Shen; Qingbo Lv; Guosheng Fu; Min Shang
Journal:  J Cell Mol Med       Date:  2022-06-26       Impact factor: 5.295

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.